Correction to: Glutamine Antagonist JHU083 Normalizes Aberrant Glutamate Production and Cognitive Deficits in the EcoHIV Murine Model of HIV-Associated Neurocognitive Disorders
1 Johns Hopkins Drug Discovery, 855 North Wolfe Street, Baltimore, MD, 21205, USA.
2 Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
3 Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
4 Department of Medicine, Icahn School of Medicine at Mount Sinai, Annenberg Building Floor 21, Room 42, 1468 Madison Ave, New York, NY, 10029, USA.
5 Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
6 Graduate Program in Neuroscience, University of Washington, Seattle, WA, USA.
7 Department of Medicine, Icahn School of Medicine at Mount Sinai, Annenberg Building Floor 21, Room 42, 1468 Madison Ave, New York, NY, 10029, USA. david.volsky@mssm.edu.
8 Johns Hopkins Drug Discovery, 855 North Wolfe Street, Baltimore, MD, 21205, USA. bslusher@jhmi.edu.
9 Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD, USA. bslusher@jhmi.edu.
10 Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD, USA. bslusher@jhmi.edu.
11 Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, MD, USA. bslusher@jhmi.edu.
12 Department of Neuroscience, Johns Hopkins University School of Medicine, Baltimore, MD, USA. bslusher@jhmi.edu.
13 Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA. bslusher@jhmi.edu.